Table 4.
Baseline 2021 | Follow-Up 2022 | |
---|---|---|
n | 143 | 51 |
Problems related to treatment of patients with long COVID * | n.a. | |
Diagnosis is difficult | 42.1% | |
Unspecific symptoms | 78.2% | |
Uncertainty regarding medications | 70.7% | |
Long course of disease | 78.9% | |
No guidelines available | 56.4% | |
Need for support related to COVID-19 * | n.a. | |
Specialized information on typical symptoms and their length | 53.4% | |
Exchange with colleagues on case reports and workshops | 45.9% | |
Online training | 37.6% | |
Diagnostic tools | 30.8% | |
Special therapies for patients with long COVID | 55.6% | |
Guidelines on long COVID | 63.9% | |
Referral options to specialized outpatient clinics | 60.9% | |
Fewer appointments can be currently offered in the following services *: | n.a. | |
Acute consultations | 20% | |
Care of chronically ill patients | 40% | |
Preventive cancer screenings | 44% | |
Preventive health check-ups | 58% | |
Self-payer services | 66% | |
Home visits | 24% | |
Nursing home visits | 22% | |
Being able to address medical and/or psychological needs of COVID patients during consultations 1 = “not able”, 10 = “fully able” |
6.7 ± 2 | 6.7 ± 2 |
Perceived limited provision of satisfactory medical care to other patients with chronic diseases 1 = “fully limited”, 10 = “not limited” |
6.2 ± 2.5 | 5.1 ± 2.4 |
Data are presented as mean, standard deviations, and percentage (n/nvalid). *, multiple responses possible, n.a., not assessed.